Mayaguez, Puerto Rico

Enrique C Abreu


Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Enrique C Abreu

Introduction

Enrique C Abreu is a notable inventor based in Mayaguez, Puerto Rico. He has made significant contributions to the field of pharmaceuticals and biosubstance handling. With a total of 3 patents to his name, Abreu's work showcases his innovative spirit and dedication to advancing technology.

Latest Patents

One of his latest patents is titled "Pharmaceutical dose form with a patterned coating and method of making the same." This invention involves a method for producing a pharmaceutical dose form by depositing a measured quantity of a first coating material on the external surface of the dose form in a patterned configuration. Additionally, a second coating material is deposited in relation to the first, forming a coating layer that enhances the functionality of the dose form. Another significant patent is the "Microtray for handling biosubstances." This invention features a fluid holding structure with an array of wells designed to contain biosubstances, along with a fluid ejection structure that dispenses these substances onto target media.

Career Highlights

Enrique C Abreu is currently associated with Hewlett-Packard Development Company, L.P., where he continues to innovate and contribute to the field. His work at HP allows him to collaborate with other talented professionals and push the boundaries of technology.

Collaborations

Some of his notable coworkers include Jose M Gonzalez and Carlos A Martinez, who share a commitment to advancing their respective fields through collaboration and innovation.

Conclusion

Enrique C Abreu's contributions to the fields of pharmaceuticals and biosubstance handling highlight his innovative capabilities and dedication to improving technology. His patents reflect a commitment to enhancing the efficiency and effectiveness of pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…